Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
gimeracil (1 trial)
oteracil (1 trial)
s-1 (1 trial)
tegafur (1 trial)
adefovir dipivoxil (hepsera) (1 trial)
blinatumomab (blincyto) (1 trial)
hs-10374 (1 trial)
lm-302 (1 trial)
metacavir (1 trial)
toripalimab (LOQTORZ) (1 trial)
cea car-t cells (1 trial)
sy-004 (1 trial)
umbilical cord mesenchymal stem cells (1 trial)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis B (Phase 2)
Hepatitis B, Chronic (Phase 2)
Hepatitis, Chronic (Phase 2)
Stomach Neoplasms (Phase 3)
Trials (8 total)
Trial APIs (13 total)